ALICIA ALLMAN: Open Payments
NPI 1033548151 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$215 in 10 payments from 8 companies in 2025. Trend: 2023 $122 · 2024 $660 · 2025 $215
Food & beverage: $215
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $33 |
| ABBVIE INC. | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
| Boston Scientific Corporation | 1 | $15 |
Products named: MOUNJARO, CAPLYTA, VRAYLAR, SHINGRIX, REXULTI, BREZTRI, Kerendia, WaveWriter Alpha Prime 16.
Industry payments across NC — which companies pay providers there.
